No. of Pages: 191 | Report Code: BMIRE00027535 | Category: Life Sciences
癌症发病率上升推动欧洲栓塞治疗市场的增长
<最常见的五种癌症是乳腺癌、前列腺癌、宫颈癌、肺癌和结直肠癌。在这五种癌症类型中，癌症相关死亡的主要原因是肺癌。尽管乳腺癌在女性中的发病率至少高出 25%，但宫颈癌仍是 2020 年的首要死因。在丹麦，男性和女性的癌症发病率最高为每 10 万人中 334.9 人。十个国家的年龄标准化率至少为每 10 万人中 300 人——丹麦、匈牙利、爱尔兰、比利时、法国、澳大利亚、荷兰、挪威、法国（新喀里多尼亚）和斯洛文尼亚。 2018年，德国估计有233,000名女性和265,000名男性新诊断出患有癌症。每年新增病例总数大约十年来一直停滞在50万例左右。栓塞用于止血或阻止血液流向肿瘤或异常组织区域。它还用于治疗肝癌和肾癌以及神经内分泌肿瘤。栓塞剂，包括栓塞微球（珠子），用于限制肿瘤的血管供应，并且可以装载化疗药物，化疗药物洗脱并扩散到组织中。血管栓塞装置（以前称为动脉栓塞装置）旨在控制动脉瘤、某些肿瘤类型和动静脉畸形引起的出血。该管道栓塞装置用于治疗颈内动脉内大型、巨型宽颈颅内动脉瘤。它有助于防止动脉瘤和肿瘤生长并对重要器官造成伤害。因此，癌症病例发病率的上升对栓塞治疗产品产生了很高的需求。
市场概览
欧洲的栓塞治疗市场分为德国、法国、英国、意大利、西班牙和欧洲其他地区。该地区的市场增长归因于癌症和脑动脉瘤患病率的增加；对微创手术的偏好不断增加；公私组织用于研究的投资、资金和赠款激增。然而，熟练外科医生的缺乏限制了市场的增长。德国是欧洲最发达的经济体之一。德国的医疗保健支出正在增加。德国在医疗保健方面的支出（占其财富的 11%）高于其他国家（英国为 9.8%）。该国的医生数量和每位患者的病床数量比英国还要多。根据《欧洲中风负担》发表的数据伦敦国王学院为欧洲中风联盟所做的报告显示，德国中风病例数约为 88,922 例，即每年每 10 万居民中有 51.7 例中风。德国的中风患病率约为 526,774 人，每 10 万居民中有 338.5 人中风。该国的中风死亡率也很高，每年有75,861人死于中风。据估计，到 2035 年，德国中风的发病率将增加 30%。此外，到 2035 年，患病率和死亡率预计将分别上升至 19% 和 40%。
< h3>欧洲栓塞治疗市场细分
欧洲栓塞治疗市场分为产品、疾病适应症、手术、最终用户和国家。< br>根据产品，市场分为栓塞剂和支持设备。栓塞剂细分市场在2022年占据最大的市场份额。根据疾病适应症，市场分为癌症、神经系统疾病、泌尿系统和肾脏疾病、周围血管疾病、胃肠道疾病等。 2022年，癌症细分市场占据最大的市场份额。根据手术方式，欧洲栓塞治疗市场分为经导管动脉栓塞（TAE）、经导管动脉放射栓塞/选择性内放射治疗和经动脉化疗栓塞（TACE）。 2022 年，经导管动脉栓塞 (TAE) 细分市场占据最大的市场份额。根据最终用户，欧洲栓塞治疗市场分为医院和诊所、门诊手术中心和其他最终用户。 2022 年，医院和诊所细分市场占据最大的市场份额。根据国家/地区，市场分为德国、法国、英国、意大利、西班牙和欧洲其他地区。 2022 年，德国占据市场份额主导地位。雅培（Abbott Laboratories）；波士顿科学公司；库克医疗有限责任公司；强生公司约翰逊;美敦力；阿坎迪斯有限公司；巴尔特美国有限责任公司；史赛克公司；加伯特有限责任公司；和 Terumo Corporation 是该地区栓塞治疗市场的领先公司。
Strategic insights for Europe Embolotherapy involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 1,050.81 Million |
| Market Size by 2028 | US$ 1,638.92 Million |
| Global CAGR (2022 - 2028) | 7.7% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 产品
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Embolotherapy refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Embolotherapy Market is valued at US$ 1,050.81 Million in 2022, it is projected to reach US$ 1,638.92 Million by 2028.
As per our report Europe Embolotherapy Market, the market size is valued at US$ 1,050.81 Million in 2022, projecting it to reach US$ 1,638.92 Million by 2028. This translates to a CAGR of approximately 7.7% during the forecast period.
The Europe Embolotherapy Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Embolotherapy Market report:
The Europe Embolotherapy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Embolotherapy Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Embolotherapy Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Embolotherapy Market
